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Previous research 1 on this subject tracked the presumed exact path the HDR source would
follow in real-time, during breast brachytherapy treatments in other to ensure accurate dose
delivery and effectively confirm actual source position. As a continuation, this research has three
objectives. Firstly, we will extract information from patient DICOM file which will be used to
perform evaluations, then we will establish communication between our C program and the new
Varex Paxscan flat panel detector (FPD). Finally, we will try to embed our C codes into a

xii

MATLAB graphical user interface (GUI) This research will attempt to improve the overall
existing system in several ways including, code optimization and trying a sample simulation of
the process in MATLAB guide app, to check the quality of the new design. Finally, all the
algorithms will be integrated into the user-friendly GUI, such that its operation can be
implemented easily. The FPD is used to obtain images resulting from the exit radiation of the
HDR source, emerging from an organized matrix of markers. The images are processed using inbuilt functions in MATLAB to obtain projection coordinates, and marker coordinates. Each
marker along with its projection constitutes a line in 3D. Using the mathematical solution for
near intersection of two 3D lines, N-markers will produce N*(N-1)/2 points of intersection and
their mean will produce a more precise source position. The changes in this position as well as
the time interval between these changes will be used to confirm the accuracy of our treatment
system using the standalone monitoring system built in this research. In the previous study the
accuracy of source position detection using the FPD was found to be in sub-millimeter. This
study which uses a new FPD with improved features is used to confirm that, but our focus here is
improvement of the previous work, as stated earlier.
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CHAPTER 1 INTRODUCTION

1.1 Background

In 1896 a German physics professor, Wilhelm Conrad Roentgen, presented lecture entitled
“Concerning a New Kind of Ray”. He called it the X-ray, with ‘x’ being the algebraic symbol for
an unknown quantity. Months after this discovery, systems were being designed to use x-rays for
diagnosis; in 3 years radiation was used to treat cancer1.
In 1898 however, the discovery of radium by the Curie’s introduced a compact source of
unvarying highly penetrating rays suitable for external or internal applications. Radium was so
rare and expensive in those early days that practitioners used trivial and less effective quantities.
Mass global exploitation of radium in several continents resulted in sufficient availability for
practical application. By 1920 radium-therapy had replaced surgery as the preferred treatment for
gynecologic malignancy. Several years of study and evolution of this new technique led to
reactor and cyclotron-produced radionuclides, with higher specific activity and lower ℽray/photon energy. This has expanded applicability and patient safety. Computed dosimetry has
improved the therapeutic ratio, and remote after-loading has eliminated radiation exposure to
personnel 2.
Skeletal remains of a 2700-year-old Russian King and a 2200-year-old Egyptian mummy have
both been diagnosed with prostate cancers3. These findings are proof that cancer has probably
existed as long as humans. Breast cancer which is the focus of this research can also be traced
back to 1600 BC Edwin Smith Papyrus, back in ancient Egypt. Since breast cancer is outwardly
visible in its most advanced stage it was easy for our ancestors to notice it enough to record it.
Throughout the ages, it has been difficult to ascertain the causes of breast cancer. Research
continues still, today.
Breast brachytherapy is a radiation therapy procedure used in modern times after lumpectomy, as
part of breast conservation solution.
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1.2 Objective of the Study
Several techniques used to monitor the performance of cancer treatment via external beam
radiation already exists. Unfortunately, they don’t exist for high dose rate (HDR) brachytherapy.
High dose rate brachytherapy according to cancer treatment center of America is a type of
internal radiation therapy that delivers radiation from implants placed close to, or inside the
tumors in the body. This research seeks to address this problem using a MATLAB based
standalone monitoring system.
This study is very important for two main reasons: firstly, nothing like this exists, and mistakes
made during radiation therapy can be very costly especially for the patient. The final product
from this research will help radiation therapists meet the quality assurance standards set by the
nuclear regulatory commission (NRC).
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CHAPTER 2 BACKGROUND

2.1 Breast Cancer
Cancer is the name given to a collection of malignant and related diseases, which can start
almost anywhere in the human body3. In all types of cancer, some of the body’s cells begin to
divide without stopping and spread to surrounding tissues. Cancer is a genetic disease that is
caused by changes to the genes that control the way our cells function, especially how they grow
and divide. Breast cancer is a disease characterized by growth of malignant cells in the mammary
glands. It can strike both males and females; but research shows that women are about 100times
more likely to develop the disease than men4. Most incidents of cancer in female breasts form
shortly before, during, or after menopause, with three-quarter of all cases being diagnosed after
the age 50. Generally older women are more likely to develop breast cancer4. In the 20th and 21st
centuries breast cancer was the leading cause of death among women worldwide but by 2012,
this only remained true in less developed countries. In high income countries lung cancer has
overtaken breast cancer as the leading cause of death among women. Breast cancer accounts for
10.4% of all cancer incidence among women, making it the second most common type of nonskin cancer (after lung cancer) and the fifth most common cause of cancer death10. In the USA
breast cancer has the highest incidence among all cancer types in females with one in every eight
to ten women being affected during her lifetime; it was estimated that 192,370 women will be
diagnosed with, and 40,170 women will die of, cancer of the breast in 2009. In the UK breast
cancer is the most common among women, although it is rare in men10. For example, in the UK,
in 2006 there were 45,822 new cases of breast cancer diagnosed; 45,508(over 99%) in women
and 314(less than 1%) in men. It has been estimated that the lifetime risk of developing breast
cancer is 1 in 1014 for men and 1 in 9 for women in the UK10.
Given that there are several types of breast cancer, the exact causes of breast cancer is unknown
till date; but it is known that both environmental and genetic factors are involved, such as
specified mutations in HER2, BRCA1, BRCA2, CHEK2 and p53 genes, which may be inherited4
or a product of evolution5.
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Figure 1: Image showing the basic physical units of inheritance. Genes are arranged in long
strands of tightly packed DNA called Chromosomes24.

2.2 Treatment and Prevention of Breast Cancer
Breast cancer dates to the prehistoric era; with its first case been assumed to have been seen in
Egypt. It was found in the remains of mummies and was also documented in ancient
manuscripts1. The earliest record of breast cancer was found in Edwin Smith Surgical Papyrus,
believed to have been written in the Egyptian pyramid Age. In these documents cancer was
described as incurable. Burning the tumor or excising it using a knife was the treatment then.
This didn’t cure cancer since cancer is malignant. The tumor would normally reoccur in the same
(ipsilateral) or different spot in the body.
The renaissance era witnessed advances in surgical procedures which led to a better
understanding of the human body via autopsy. The anatomy of the breast was later described by
Andreas Vesalius, which laid the foundation for the treatment of breast cancer1. Up until the 18th
century surgeons amputated the breast as a form of treatment; but surgical conditions improved
in 1846 when Morton discovered anesthesia1. In 1894 Halsted published his work, which was
widely accepted by surgeons in the late 19th century to become the standard for the treatment of
breast cancer for the next one hundred years. This method was called the Halsted radical
mastectomy. In 1912 Murphy abandoned the Halsted operation, and developed a new method
which did not include the removal of the pectoral muscle. This approach marked the beginning
of the modified radical mastectomy; various clinical trials in the mid 1900’s proved this method
to be as effective as radical mastectomy for early stage breast cancer1.
4

Figure 2: Structure of the human breast

Breast cancer has a remarkably high five-year survival rate. Early diagnosis via processes like
self-examination or mammography, greatly improves the odds of survival. Survival rates is lower
for cancer that have spread locally, and exceptionally low for cancers that have metastasized or
spread to distant body parts4.
Treatment of breast cancer after it is discovered to be malignant may entail surgery, radiation, or
chemotherapy. Biological treatment is equally an option. Surgery is often the first method of
treatment and might come in the form of lumpectomy, which removes only the cancerous mass
and a small amount of surrounding tissue, or mastectomy which removes the entire breast. A
modified radical mastectomy removes the breast along with adjacent lymph nodes. Side effects
associated with surgery includes: changes in arm or shoulder mobility, swelling, infection,
numbness, and when the lymph nodes are taken, fluid builds up in the region that they were
taken from. Lumpectomy or mastectomy is usually followed by cosmetic or reconstructive
surgery4.
Currently, there’s no known way to completely prevent breast cancer, but the risk of developing
advanced disease can be reduced4. Prevention techniques includes: maintaining a healthy body
weight, reducing alcohol consumption, and ceasing to smoke. Self-examination as well as
professional annually mammogram is recommended for women aged 40 and older, while for
women between 20 and 39years, mammogram is recommended every 3years. In some special
cases, women who are at extreme risk due to strong family history or the presence of mutated
BRCA genes, may opt for preventive mastectomy.
5

2.3 Radiation Therapy and Other Less Invasive Treatment Techniques
Radiation therapy, chemotherapy and biological therapy are less-invasive treatments for breast
cancer6. Radiation therapy is usually employed to shrink tumors before surgery or to destroy
small amounts of cancerous tissues remaining after surgery. The side effects after radiation
includes: swelling, or thickening of the breast, vomiting, diarrhea, or skin irritations resembling
sunburn 4. Chemotherapy involves the use of chemicals to destroy cancerous cells, but this
method is also known to attack normal cells, to some degree, causing side effects that include
hair loss, immune suppression, mouth sores, fatigue, and nausea. Biological therapy entails the
use of chemical inhibitors to block the hormones that stimulate growth of cancer cells.

Figure 3: Computed Tomography Scanner(CT). CT scanners are often used in both radiation
therapy and brachytherapy to obtain treatment plan information24.

To implement radiation therapy, CT scanners are used to obtain pictures of the inside of the body
via a computer connected to an x-ray machine24. Currently, there are several external beam
radiation techniques in existence, each suited for a treatment depending on treatment goals.

6

Figure 4: Linear accelerator (LINAC) used for external beam radiation therapy24.

2.4 Breast Conservation Surgery (BCS) Followed By Radiation Therapy (RT)
According to American Cancer Society (ACS), breast conservation surgery/treatment (BCS) is
an operation to remove the cancer while leaving as much normal breast as possible2. At times
some surrounding healthy tissues and lymph nodes are usually also removed. The amount of
breast removed depends on the several factors like the size and location of the tumor. Breastconserving surgery is sometimes called lumpectomy, quadrantectomy, partial mastectomy, or
segmental mastectomy. This technique is usually an option for in patient in the early stages of
cancer. At the completion of lumpectomy, a pathologist will use a microscope to look at the
edges of the removed tissues. If no cancer cells are found at any of the edges of the removed
tissue, it is said to have negative or clear margins. The presence of positive margins means that
some cancer cells may still be in the breast after surgery, so the surgeon might need to remove
more tissue in an operation called re-excision. If at the end of this second surgery, cancer cells
are still found then a mastectomy might be needed.
The advantages of BCS includes: it allows a woman keep most of her breast which will also
require the application of more radiation via brachytherapy or radiation therapy, given by a
radiation oncologist (doctor who specializes in radiation).
The side effects of this may include pain, a scar and/or dimple where the tumor was removed, a
firm or hard surgical scar (Fibrosis), and sometimes lymphedema, a type of swelling in the arm2.
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Figure 5: After effect of lumpectomy/partial mastectomy

Patients that desire breast reconstruction are usually advised to talk to their doctor before the
surgery2.
Several studies have been done on breast conservation surgery to study long term effect on
patient body and the possibility of reoccurrence. In one study7, a nomogram was used to predict
the 10year ipsilateral breast relapse (IBR) after breast-conserving therapy (BCT) for breast
cancer was developed based on the boost-no-boost trial with a concordance probability estimate
(CPE) of 0.68. The aim of this project was to validate that algorithm. 1787 breast cancer cases,
treated with BCT and radiotherapy from 2000 to 2007, at the University Hospitals Leuven were
identified without missing data of the nomogram variables. Clinicopathological factors were
assessed, as well as the validity of the prediction model in term of discrimination and calibration.
The median follow-up time used in this research was 10.75years. The 10year IBR rate was 1.4%.
This research concluded that the predictive model for IBR in breast cancer didn’t work, in this
more recent study population. In another study8, researchers perform a study to compare
outcomes after breast conservation treatment with Iridium-192 implant boost versus electron
boost (Brachy boost is the administration of lower dose[10-25Gy], implantable radiation in
addition to external beam radiation of 45-70Gy 2). Data of 141 patients treated via whole breast
brachytherapy followed by iridium-192 boost after BCS between 1977 and 1983, were gotten
and matched 1:1 to patients treated with electron boost. Outcome measures included survival,
local reoccurrence, cosmesis, and complications. Median follow-up was 16.7 and 12.6years for
8

the implant versus electron group. The rate of reoccurrence, freedom from distant metastases and
overall survival at 10/20years did not differ between the groups nor did patterns of first failure.
Patients in the electron group were found more likely to have good/excellent cosmesis than those
in the implant group 1year after radiotherapy. This trend continued through 10years but didn’t
reach statistical significance at years 5/10. Complications rates were similar although patients
receiving electron boost seemed less likely to develop breast fibrosis than did those receiving
implant boost (23/141 vs 58/141, respectively, incidence rate ratio 0.7). The conclusion from this
research from a 20year data was that, there was no difference in the rate of local occurrence,
freedom from distant metastases, overall survival, or patterns of failure between groups treated
with these two well-described radiotherapy boost techniques. Better cosmesis was observed in
the electron group in 1year after radiotherapy, with a trend continuing for 10years. The incidence
of complication was similar between the groups, with a trend toward increased fibrosis in
patients receiving implant boost. In a third study9, which was done to report the 2year cosmetic
outcome of a randomized trial comparing prone and supine whole-breast irradiation in largebreasted patients, one hundred patients with cup size>=C (European) were included. Before and
2-years after radiation therapy, clinical endpoints were scored, and digital photographs were
taken with the arms alongside the body and with the arms elevated 180degrees. Three observers
rate the photographs using the 4-point Harvard cosmesis scale. Cosmesis was also evaluated with
the commercially available breast cancer conservation treatment / cosmetics results software
(BCCT.core). Two-year follow-up data and photographs were available for 94 patients (47
supine treated and 47 prone treated). Patient and treatment characteristics were not significantly
different between the 2 cohorts, with a worsening of color change occurring more frequently in
the supine than in the prone cohort (19/46 vs 10/46 patients respectively). Five patients in the
prone group which made up 11% of the group’s population and 12 patients from the supine
group which made-up 26% of the group’s population, presented with a worse scoring of edema
at 2-year follow-up. For retraction and fibrosis, no significant differences were found between
the 2 cohorts, although scores were generally worse in the supine cohort. The cosmetic scoring
by 3 observers did not reveal differences between the prone and supine groups. On the
photographs with their hands up, seven patients in the supine group versus none in the prone
group had a worsening of cosmesis of 2 categories using the BCCT.org software.
All in all, breast conservation surgery followed by brachytherapy are particularly important
aspects of breast cancer treatment, after which patient caregivers are given instructions on how to
care for the surgery site after surgery2. Caregiver instructions includes but are not limited to: how
to care for the surgery site and dressing, how to care for your drain if you have one(a plastic
rubber tube coming out of the surgery site that removes the fluid that collects during healing),
how to recognize signs of infection, bathing and showering after surgery, when to call the doctor
or nurse, when to start using your arm again and how to exercise the arm to avoid stiffness, when
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you can start wearing a bra again, what to eat and not to eat, use of medicines including pain
medicine and antibiotics, any restrictions on activity, what to expect regarding sensations of
numbness in the breast and arm, what to expect regarding feelings about body image, when to
see your doctor for a follow-up appointment, and referral to reach to recovery volunteer.

2.5 Accelerated Partial Breast Irradiation
Accelerated partial breast irradiation (APBI) according to cancer treatment center of America
(CTCA) is a breast radiation therapy in which focused radiation is delivered specifically to the
part of the breast where tumor is removed11. APBI treatment can be administered via
brachytherapy or through external beam techniques, such as tomotherapy. APBI is normally an
option when treatment involves: a small tumor, there is a clear surgical margin after a
lumpectomy and preferably no lymph nodes containing cancer. It’s a preferable option for
women with early stage breast cancer11.
Various approaches for APBI have been developed, they include10: multicatheter interstitial
brachytherapy, balloon catheter brachytherapy, conformal external beam radiation therapy, and
intraoperative radiation therapy (IORT).
Some advantages of APBI for breast cancer includes11:
•

•
•

With APBI, breast radiation therapy treatments are focused specifically on the part of the
breast where the tumor was removed, so radiation is contained to the tumor cavity as
much as possible.
Because radiation is so targeted, it affects less of the healthy tissue and organs close to
the breasts, including the lungs, heart, ribs, muscles and skin.
APBI can be given in a more condensed schedule than some other radiation therapies for
breast cancer (5days instead of 6 to 7weeks).

One technique that like APBI is intensity modulated radiation therapy (IMRT); the only
difference being that it applies beam from an external source (External Beam Radiation TherapyEBRT), rather than via brachytherapy which is the subject of this research. This technique is
sometimes recommended by the care-team based on patient plan and individual needs. It’s
usually administered for people who’ve had previous breast cancer radiation therapy and are
experiencing recurrent tumors in the treatment area11. Some of its advantages includes 11:
•

IMRT employs an advanced computer program to accurately map your radiation dosage
in 3-dimensionss, based on the breast tumor size, shape and location. It uses advanced
technology to manipulate photon and photon beams of radiation to conform to the shape
of the tumor.
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•

IMRT directs radiation at the breast tumor and modulates the intensity of the radiation
beams, helping to spare healthy tissues surrounding the breast tumor.

•

IMRT allows each dose of radiation to be custom-tailored according to the geographical
shape of the breast tumor.

2.6 Brachytherapy and Breast Brachytherapy
The word brachy means short distance in Greek. Brachytherapy is a type of internal radiation
therapy which uses a high activity source of short-range radiation such as Ir-192 sealed (enclosed
within a capsule) and placed inside or close to the treatment location, to destroy cancer cells and
shrink tumors17. This technique allows doctors to deliver higher doses of radiation to more
specific areas of the body, compared with other conventional forms of radiation therapy such as
external beam radiation where radiation is projected from a machine outside of the body. It is
usually performed on outpatient basis. The advantages of brachytherapy include: fewer side
effects as compared to some external beam radiation techniques since less healthy tissues are
exposed, overall shorter treatment time (HDR) which helps reduce the chances of surviving
cancer cells to divide and grow between each radiotherapy dose interval, and stability, in the
sense that even when the patient moves during treatment the radiation sources retain their correct
position in relation to the tumor. In 1929 Geofrey Kenynes was the first to publish results with
brachytherapy used as the only method of treatment1.
The methods used to deliver breast brachytherapy includes: interstitial breast brachytherapy,
intracavitary breast brachytherapy (balloon brachytherapy), intraoperative radiation therapy,
permanent breast seed implantation, and non-invasive brachytherapy which uses mammography
for target localization and a HDR source. Dose rate in brachytherapy is usually measured in
grays per unit time such as grays per hour (gy/hr) . A treatment is usually classified as high dose
rate when it exceeds 12Gy/hr.
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Figure 6: Concept of Brachytherapy4.

Computed Tomography (CT) images are used to obtain information about treatment location.
But it doesn’t provide information about the unique size and shape of the tumor, or even the
organ at risk (OAR)16. This could lead to tumor under-dosage or over-dosage which increases the
chances of cancer cells reoccurring. The success or failure of HDR brachytherapy is therefore
determined by the exact position of the radioactive source used in treatment. Accurate or optimal
positioning of the source is essential for delivering the desired dose to the target area while
avoiding injury to neighboring tissues. Optimal dose delivery depends among other things on the
accuracy of catheter placement17.

2.6.1 Multicatheter Interstitial Brachytherapy (MIB)
There are several brachytherapy techniques in existences, namely: interstitial implants,
intracavitary devices with single/multilumen balloons, hybrid applicators, and irradiation with
low energy x-ray. Of all APBI techniques currently, multicatheter interstitial brachytherapy
(MIRT) has the longest follow-up and has a level 1 evidence as a valid treatment alternative to
whole breast irradiation after breast conserving surgery (BCS)12. It involves the use of multiple
catheters to administer radiation to a cancer tumor. This technique was initially developed to
provide boost radiation after whole breast radiation therapy10. Flexible after-loading catheters are
placed through the breast tissues surrounding the lumpectomy. The catheters are inserted at 1 to
1.5cm intervals in several planes; firstly to ensure adequate coverage of the lumpectomy cavity
plus margins, and secondly to avoid hot and cold spots (areas of too much and too little
irradiation respectively)10. Multiple catheters are placed in the breast using a free-hand or
template-guided approach10. Catheter insertion requires a high level of experience to produce an
implant of excellent quality. In MIB, either low-dose-rate(LDR) or high-dose-rate(HDR)
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brachytherapy may be used. With LDR, sources of Ir-192 sources are implanted for
approximately 2 to 5days while the patient is admitted as an inpatient. High Dose Rate (HDR)
however, which we use in this research is an outpatient procedure, fractionated over the course
of a week, with each treatment varying between seconds to minutes10. The dose used is usually
based on biological effective dose (BED).

Figure 7: Illustration of multi-catheter interstitial brachytherapy10.

To plan the right positions for the catheters, ultrasound or computed tomography (CT) imaging
can be used, but the treatment plan is always based on postimplant CT images12. With CT
imaging, the 3D target volume can be defined more precisely and delineation of the organs at
risk volumes is also possible. Parameters calculated from dose-volume histogram can be used for
quantitative plan evaluation. The catheter reconstruction is also easier and faster on CT images
compared to X-ray films. In high dose rate brachytherapy, using a stepping source, several
forward dose optimization methods (manual, geometrical, on dose points, graphical) are
available to shape the dose distribution to the target volume, and these influence dose
homogeneities to different extent. Currently, inverse optimization algorithms offer new
possibilities to improve dose distribution further considering the requirements for dose coverage,
dose homogeneity, and dose to organs at risk simultaneously or automatically.
It is of utmost importance to place the catheters in the right positions. To get an acceptable dose
distribution, the planning target volume (PTV) must be geometrically covered by the catheters.
To achieve this different imaging methods can be used. With ultrasound guidance the deepest
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needles can be inserted manually if the resection cavity is visible, and the rest of the catheters are
placed with a template, which can ensure an even spacing between the catheters. Another
approach is when the superficial needles are inserted as first under ultrasound guidance followed
by the deeper needles with template guidance, but the artefacts from the shallow needles may
cause visibility problem. If the needles are manually inserted using ultrasound imaging, the PTV
contour and all entry and exit points must be marked on the skin surface to plan the needles
distribution. However, the best method is when a 3D imaging with full anatomical information
about the resection cavity, PTV, and organs at risk (OARs) is available before insertions are
done. Then the number and positions of the catheters can be determined using a 3D rendered
image with a template placed around the breast as shown in the image below. If the intention of
the treatment is delivering a boost dose, steel needles can be used with 1-3fractions, but in
monotherapy treatment with 7-10fractions, the needles are replaced with plastic catheters for the
sake of patient’s convenience.

Figure 8: 3D rendering image of patient anatomy with a template on the right breast in needle’seye-view after pre-implant computed tomography imaging. The red-colored planning target
volume is projected into the template with the holes and the light-blue dots show the planned
positions of the catheters12.

Any imaging technique is used before the implantation, after the insertions of the catheters, a
new CT imaging is needed for planning purpose. Generally, the patient is positioned in the CT
table in the same way as for EBRT making sure the same anatomical positions at boost treatment
as for external irradiation. Generally, 3mm slice thickness is acceptable for accurate catheter
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reconstruction and target delineation. Organs at risk and resection cavity must be outlined, and
the PTV should be created according to the available guideline. Using special markers in the
catheters with good visibility but without artefact is a great help during catheter reconstruction12.
Nevertheless, without markers, the catheters can be also visualized merely by the inside air as
shown in the figure below, and with proper windowing, the reconstruction can be properly
performed. Catheters should be numbered or uniquely labelled so that each individual catheter
can be identified. By selecting a lower isodose level for dose prescription, the target coverage
can be slightly improved, but the dose to normal tissues might increase12.

Figure 9: A transversal and sagittal computed tomography slice with implanted catheters. In
most of the catheters, special markers are inserted (shown with the white lines/dots) but some of
them do not have any markers and only the inside air makes them visible (shown with black
lines/dots)12.

With the introduction of image-guided implantation techniques, the treatment plans improved
considerably compared to traditional fluoroscopy-guided implantation (continuous x-ray image
on monitor, like x-ray movie) and planning12. The percentage of patients satisfied with the
dosimetric goals of target coverage and dose homogeneity increased from 42% to 93%, when
CT-guided technique was used instead of fluoroscopic guided free-handed catheter insertion
technique12.
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2.6.2 MammoSite Balloon Brachytherapy
Balloon based brachytherapy include: MammoSite, Axxent electronic brachytherapy, and
Contura 10. MammoSite balloon brachytherapy is an approach for APBI. The MammoSite
brachytherapy (MSB) system applicator was developed to be more reproducible, easily applied
and better tolerated. The MammoSite catheter consists of a silicone balloon connected to a 15cm
double-lumen catheter that is 6mm in diameter. The catheter has both a small inflation channel
and a channel for the passage of Ir-192 HDR brachytherapy source. The source channel runs
centrally through the length of the balloon. The balloon is inflated with saline solution mixed
with a small amount of contrast material to aid visualization. The balloon is then inflated to a
size that would completely fill the lumpectomy cavity and ensures conformance of the tissue to
the balloon. An Ir-192 radioactive source connected to a computer-controlled HDR remote afterloader, is inserted through the catheter into the balloon to deliver the prescription radiation dose.
The MammoSite applicator can be placed into the lumpectomy cavity at the time of surgery or in
a separate procedure after surgery. In the latter case, the applicator can be inserted under ultrasound guidance either through the lumpectomy scar or via small separate incision. Following
placement, a computed tomography (CT) scan is performed to assess the quality of the implant
and for use in radiation planning. Quality of implant is determined by examination of three
parameters: balloon conformance to the lumpectomy cavity, distance from the surface of the
balloon to the skin surface, and the symmetry of the balloon in relationship to the central
catheter. Treatment planning parameter are: the diameter of the inflated balloon, the planning
target volume, and the dose distribution. While a minimum balloon-to-skin distance of 5mm is
required a threshold of at least 7mm is strongly recommended. Conformance of the balloon to
the lumpectomy cavity is assessed by quantifying the volume of the planning target volume
(PTV) that is filled by air or seroma fluid. Adequate conformance is considered to have been
achieved when less than 10% of the PTV is composed of fluid or air. A symmetric implant in
relation to the source channel is also essential for adequate dosimetry. A non-symmetrical
implant can result in dose inhomogeneity in the surrounding tissues since the MSB device
contains a single central source channel that does not allow for shaping of the radiation isodose
curves in the direction perpendicular to the central channel10.
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Figure 10: The MammoSite Balloon Applicator12.

Recently, a Multi-lumen (4 lumen) device as seen below with the potential to eliminate some of
the drawbacks of the single lumen device as in the figure above have been introduced.

Figure 11: MammoSite Multilumen System12.

Apart from the above MammoSite systems there are several other modifications that have been
designed for certain kinds of treatments or applications.
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Several studies have been carried out on MammoSite balloon brachytherapy. In one study13,
results showed lower-rates of local and ipsilateral breast disease failure in a well-defined cohort
of MBT patients with mature follow-up. In another study 27 which measured the extended
outcomes of APBI using MBT, results showed that long-term single-institution outcomes suggest
excellent tumor control, breast cosmesis, and minimal late toxicity.

2.7 Remote Afterloader and Applicators
After-loading is the technique used to deliver radiation sources. This is different from manual
delivery of brachytherapy where the source is delivered into the applicator by the operator, and
which is only used in few cases involving low dose rate (LDR) sources. The after-loader as
indicated below by the red arrow, is a box-shaped device which passes the radiation source
through a set of catheters (blue arrow) to the treatment site. It receives instruction from a control
station before performing any operation. In this research, the after-loader will be used to deliver
real treatment.

Figure 12: Afterloader, Catheter and Applicator System17.

The applicator on the other hand is a device that comes in different designs. It is connected to the
ends of the catheter, and they both provide a proper guide for the radiation source to the
treatment site.
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2.8 High Dose Rate Radiation Source
The main challenge in high dose rate brachytherapy (HDR) is to deliver a prescribed radiation
dose to a tumor while limiting the dose delivered to surrounding organs and tissues16. Ir-192 is
the HDR radiation source used in this research. When using the HDR source it is important that
the source positions and dwell times meet the requirement for the prescribed dose. Therefore, it
is particularly important to measure the real-time position and the dose distribution of the Ir-192
source in after-loading HDR brachytherapy16. The mean energy and half-life of Ir-192 are
370KeV and 74.2d, respectively16.
Most HDR brachytherapy treatments are done with one weekly treatment for a period of up to
four weeks or with one or two treatments per day for up to five days. The radiation delivery only
lasts a few minutes while the procedure which is also called a session, including: patient setup,
applicator positioning, treatment planning and treatment delivery itself, lasts up to a few hours28.
Compared to permanent implantation, which is used to treat prostate cancer, the high dose rate
afterloading therapy is used on a broader level. It can be used for the treatment of cancer in the
parts of the body identified in Figure 13 below2.
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Figure 13: Body sites that can be treated with HDR brachytherapy4.

2.9 Radiation Treatment Planning Workflow
2.9.1 Catheter Implantation
A clinical examination is performed, and several CT images of the tumor is taken for analysis.
These CT images contain information including the coordinates of the region occupied by the
tumor in 3D (Tumor cavity)10,12. The result of this analysis is used to design a treatment plan
which can be delivered to the patient. Catheters are implanted either during the lumpectomy
surgery or a few days later. The catheters are placed using CT-guided 3D planning software such
as Pinnacle Planning Software1. Based on all the scans (pre-implant scans) the software outlines
the cavity and creates a design for the catheter placement which includes catheter number,
catheter planes, intercatheter spacing and direction of placement1.
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Figure 14: Tumor outline and planning for catheter placement1.

Using this design, the entry-exit points for the catheters are marked on the skin of the
patient 2-3 trocars are inserted in the marked points followed by the CT scan to evaluate the
position of the trocar and the tumor cavity1. Based on the obtained information the remaining
trocars are inserted and the CT scan is acquired to evaluate the accuracy of the trocar placement.
Once the trocars are precisely placed they are replaced by afterloading catheters and tightly
secured by buttons at both ends. Many-a-time, buttons of different colors are used to indicate
different planes as a form of quality assurance procedure. The catheters are then numbered, and
their lengths are recorded.

Figure 15: Catheter implant for APBI treatment1.
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After this procedure, the MammoSite device to be used in treatment is implanted using an open
technique1(during lumpectomy surgery) or using ultrasound techniques to estimate the tumor
cavity (post-lumpectomy). Once the device is in place CT scans are used to evaluate the quality
of the implant.

2.9.2 Creation of Phantom Patient and Plan Optimization
Since this is an experimental procedure, a phantom is initially used to validate the treatment
procedure before it is applied to a real patient. A virtual or actual radiation source is used with
the phantom to confirm the treatment plan (depending on preferred option). At this stage cold
shots (too little irradiation) and hot spots (too much irradiation) are identified.
Measurement of the length of the catheter inserted into the phantom, is taken using a flexible
circular rule which is normally inserted into the catheter to get the exact distance where the
source will be placed. The source applicators are then placed in the target region (treatment
area/target). Imaging techniques such as x-ray are then used to ensure correct positioning of the
applicators.

2.9.3 Treatment Planning
The image dataset acquired from the procedure in 2.9.2 above is used for 3D dosimetry planning
of the HDR treatment1. The dataset is electronically transferred to the treatment planning station.
The planning station used for this research is Brachyvision Planning System, by Varian Inc. The
lumpectomy cavity is then contoured along with other anatomical structures, after which
treatment planning tools are used to expand the cavity by 1-2cm, keeping a 5mm distance from
the chest well, pectoral muscle and the skin surface. Several factors determine this expansion
such as: the size of the breast, the location and the lumpectomy cavities. The new established
volume is now called the planning target volume1.
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Figure 16: Contouring of tumor cavity and target volumes1

At this point, the applicators are outline using the 3D planning software and the CT images. The
catheters are reconstructed along the dummy wire from one end of the catheter to the other. Each
catheter is numbered and defined by several dwell positions.

Figure 17: Explaining outlining of applicators and definition of dwell positions1.
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Next, the planning system designs a treatment plan by defining dwell times for each
dwell position for all catheters target volumes. The aim of this plan is to perfectly deliver the
prescribed dose to the target volumes (Dose optimization)1.
For a well delivered plan, the dose homogeneity index should be as high as possible. Dose
Homogeneity Index (DHI) is used to measure the dose homogeneity, with the formula given
below1,
DHI = (V100 – V150) / V100
V100 represents the absolute volume of tissue receiving 100% of the prescribed dose and V150
is the volume receiving 150% of the prescribed dose. The treatment plan is then evaluated using
Dose-Volume Histograms.
Now that our treatment plan is ready, it is exported to the computer station used to control the
afterloader. This plan contains all the dwell positions with their accurate dwell times, for each
applicator. The catheter lengths are added to the appropriate applicator and fed to the treatment
delivery system. The Ir-192 radioactive source of 34Gy1 is used for treatment, via the afterloader,
in a selected number of fractions over several days.
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Figure 18: Sample Treatment plan

2.9.4 Software
Most of the software used in this research comprises of MATLAB codes. Communication with
the flat panel detector will require the use of Embedded C code which will be integrated with
MATLAB via MATLAB Exchange Files(MEX), such that the entire setup can be controlled via
the MATLAB GUI. The software used by the actual treatment system is separate from that
which we design in this research. Ours is meant to work alongside the main treatment system,
and act as a standalone monitoring system.
Now that we have an overview of the actual structure of our software, it is important to note that
certain modifications had to be made to get all our codes running properly. Figure 19, below
shows the location of the sample codes created, on the computer when the software that comes
along with the flat panel detector is installed. The software only works on Windows 7, and I
believe the same thing applies to the driver that ensures communication between the detector and
the software. Since we intend to control our system from MATLAB, we must create a custom
design using the sample embedded C-program provided to us. For optimal performance this code
had to be modified to reduce its total size and runtime. The reduced/modified code is then
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packaged as a MEX file to make it compatible with MATLAB. This MEX file along with the
image processing algorithms and other native MATLAB codes that are designed to extract
information from the DICOM files, are made to all run together for our design to properly
function.
To ensure optimal performance, our image detector has to have a high/fast read-out time, and our
MATLAB image processing algorithms need to run at very high speed to reduce delay, and to
ensure that we get results almost in real-time, if not in realtime17.

Figure 19: Shows location of sample C codes after installation of Varian software

Communication with the flat panel detector is done over ethernet. As recommended by the
manufacturers communication is done over this IP address: 192.168.2.23. The figures below
show how we navigated to and set the IP on the computer to make this work.

Figure 20: First step to modify Ethernet IP of the flat panel detector
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Figure 21: Second step to modify ethernet IP of the flat panel detector

Figure 22: Third step to modify ethernet IP of the flat panel detector

Figure 23: Fourth step to modify ethernet IP of the flat panel detector
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2.9.5 Quality Assurance (QA) Procedures:
Factors resulting in dosimetry errors which potentially affect the efficacy of treatment includes:
anatomical changes between the time of planning and surgery, human error in measuring and
entering data to the after-loader system, and changes in the catheter location during the treatment
or from fraction or fraction.
Quality Assurance is a major factor in brachytherapy; physicians are usually encouraged to make
the best use of radioactive treatment materials to protect healthy tissues in the patient as well as
protect the environment, as per regulations set by the nuclear regulatory commission (NRC)19.
It is doubtful that the use of radionuclides for brachytherapy can be replaced in the near term by
some non-radionuclide equivalent source of radiation. Doctors see it as superior to external
radiation, since it causes the least damage to surround tissue. X-ray units are simply too large as
well for internal use and there is no current adequate alternative to the use of radionuclides in
brachytherapy20.
In some parts of the world, total safety is a serious concern; for example, in Canada, where a
National Sealed Source Registry (NSSR) and the Sealed Source Tracking System (SSTS), were
developed. These systems contain information on the movement and location of high-risk
radioactive sources in Canada, from their manufacture to their final disposition (cradle-to-grave
approach)21.
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CHAPTER 3 METHODOLOGY

This experiment was setup in the basement of the North hospital in VCU Massey cancer center,
in the brachytherapy imaging suite located in the basement. The HDR source tracking setup
comprised of the: imaging source, a well-defined array of markers and a detector. The HDR
source (from the after-loader) was used for all imaging purposes. The flat panel detector used
here is of higher sensitivity as compared to the one used in the previous research 1; it was used as
the image detector for all the test runs. For image acquisition purposes, ball bearings (BBs) of
4mm to 6mm in diameter purchased from Pleasants Hardware and a local bicycle shop were used
to create the array of markers.
As shown in Figure 24 below, the basic experimental setup has the HDR source positioned at
some distance away from the detector, with the set of markers placed at some distance between
the source and the detector. In Figure 24 we have two planes namely: the marker plane and the
detector plane. The surface of the new flat panel detector makes up the detector plane while the
top surface of the plexiglass makes up the marker plane. Assume P1 and P2 in Figure 24,
represents two markers placed at some random position on the plexiglass. The system of axis for
this experiment was chosen such that the center of the detector acts as the origin, with the x-axis
and y-axis running through the center of the detector and the z-axis perpendicular to the center of
the detector. This system made calculation convenient. A single test applicator with five dwell
positions placed along the x-axis was used for all our experiments.
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Figure 24: Schematic of the experiment

Take point S as one of the dwell positions where the HDR source will be active for a set amount
of time. When the HDR source reaches point S and is active, it will produce projections of the
various markers (BBs) on the detector; marker P1 produces projection P3 and marker P2
produces projection P4. To define a line in 3-D which passes through the marker and its
projection we need to know the coordinates of the markers and its projections with respect to the
origin in space. Line p is defined by the combination of marker P1 and its projection P3, while
line q is defined by the combination of marker P2 and its projection P4. The intersection of
imaginary line p and q in 3-D space constitutes the original position of the source S. This
procedure is repeated to track the other dwell positions.
Since two non-parallel lines don’t necessarily intersect in space, as they could go over one
another without touching, we might not have any point as common points. Thus, plotting the true
intersection of line p and line q in space is very unlikely. To resolve this, we compute the
shortest distance between two lines, by connecting them in 3D using a line segment which is
perpendicular to both lines. The shortest of such line segment is unique and is considered as the
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intersection of the two lines in 3D. This distance is represented by D, and it’s the shortest
distance between line p and line q, while P and Q represent the corresponding two points
contained on line p and line that make up D. The mean of the coordinates of point P and Q would
give us the 3-D coordinates of the source position.
The explanation above uses just a pair of markers; in this study a well define matrix of markers is
used. The procedure above is repeated for all possible combination of marker projection pairs. N
markers would produce N*(N-1) / 2 combination of marker projection pairs. Each pair will
produce a shortest distance D, a P and a Q. The average over all the P’s and Q’s will give the
most accurate position of the source.

3.1 DICOM Files
Digital Imaging and Communications in Medicine (DICOM) is a standard for storing
and transmitting medical images enabling the integration of medical imaging devices such as
scanners, servers, workstations, printers, network hardware, and picture archiving and
communication systems (PACS) from multiple manufacturers15. It describes how to compose
messages to send between imaging modalities (example: CT, MRI) and defines a set of
operations for transmitting them across a network. These messages can also be written to files for
offline storage on a picture archiving system, CD, or other type of storage device. DICOMformatted messages combine images and metadata to create a rich description of a medical
imaging procedure. This format is extremely detailed, with a specification that is more than 2500
pages long15.
A typical DICOM file contains numerous attributes or metadata. The reason for this is that
DICOM message encapsulate all the information about medical imaging procedure, including
details about the patient, study, imaging modality, and image series in addition to the image
frame stored in the file. Together, all these attributes comprise an information object.
DICOM makes it easy to acquire and put medical images into a file. It is becoming more
prevalent in the medical field. Many medical device manufacturers and software manufacturers
are adding DICOM to just about any product that can work with medical images and data.
Using MATLAB with the image processing toolbox provides easy access to medical images,
modality, metadata, and patient information within DICOM files. They also provide numerical
and image processing algorithms, GUI-building tools and visualization techniques. With
MATLAB, the image processing toolbox and DICOM we can view medical images, design and
test new modalities, and create GUI-driven medical image analysis systems.
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Figure 25: Sample DICOM metadata15.

The DICOM file used here holds several groups of data of different datatypes (metadata). These
groups are called fields and could contain sub-groups of various datatypes as well. It basically
has a tree structure, which opens as you go deeper into it, just like a folder or directory. Figure
26, below show the content of the DICOM plan file (struct file) read into a variable named
“infop” in MATLAB. It is of struct datatype.

Figure 26: Sample Content of a DICOM file
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3.2 Testing Imaging Geometry and Image Quality
The radiation produced by the HDR source must be strong enough to be used as an imaging
source. In other to resolve the problem of image quality when using a given HDR source, the
new Varian detector has a higher sensitivity. The flat panel detector (FPD) is optimized for the
low energy of the X-ray imaging source (80 – 120kV range). The average energy of Ir-192
source used for HDR treatments is approximately 380KeV, well outside of the range for which
the FPD is optimized. Given a likely distance of 0.5m-1.0m between the radioactive treatment
source Ir-192, and the FPD, the intensity of the beam is going to be significantly less than that of
the X-ray source, which will translate in low signal to noise ratios (S/N ratios).
The aim of this test is to define the best imaging geometry for the experiment: the best possible
design of markers, optimal position of the source and the detector, and to test image quality. A
good projection of markers produced by the HDR source for different source-detector distance
can be isolated and labeled.
A good imaging geometry would also include a well-defined matrix of markers and an optimal
height between the markers and the detector, such that every marker of the matrix produces a
projection on the detector. The concept of estimating optimal height is really finding the best
compromise between large image displace and good image quality. Let’s assume the source
moves from position S1 to position S2 as in Figure 27, when the markers are placed away from
the source and closer to the detector the resulting scatter will be significantly less, thus producing
good quality images. But the displacement of the marker projection on the flat panel detector for
a given source displacement would be very small relative to the detectors resolution that is
0.388mm. When the markers are placed closer to the source and away from the detector,
although the displacement of the projection of the markers would be larger, larger amounts of
scatter would deteriorate the quality of the image.

Figure 27: Explaining position of markers for a good imaging geometry
33

On average a breast cancer tumor is less than a 15cm × 10cm × 10cm cube. Thus, for the
calculations we assumed that the source would travel a maximum of 15cm in the x-axis, and
10cm in the y-axis within the tumor. The dimension of the detector is 40cm × 30cm. A region
must be defined such that when the matrix of markers is placed within that region, every single
marker in the matrix would produce a projection on the detector.
Looking at Figure 28, let’s assume the source-detector distance is 60cm, and assume that line AB
represents the 15cm side of the cube that the source is supposed to travel within the tumor, and
line PQ represents one side of the detector.

Figure 28: Explaining the region of interest for the position of the markers1.

When the source is at point A, all markers within the area covered by the blue dotted lines will
produce projections on the detector. Now when the source is at point B all markers with the area
covered by red dotted lines will produce projections on the detector. The intersection of these
two areas or regions represents our region of interest. Within this area of interest, we need to find
an optimal height where there is no compromise on image quality or distance of image
displacement. At the same time, it must give room for decent amount marker projections to be
produced on the detector. Looking at Figure 28 above it was discovered that 20cm to 30cm is a
good height to place a set of markers such that all projections fall on the detector1.
Once the range of distance between the marker and the detector has been defined, the next step is
to design the basic experiment by placing the Plexiglas detector setup and acquire images using
the HDR source. Markers with different diameters were placed 1cm to 2cm apart on top of the
plexiglass surface. The markers were placed along the two-central axis of the detector. The
source-detector distance was varied from 40cm-70cm with an increment of 5cm, keeping the
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distance between the markers and the detector constant at approximately 20cm. Images were
acquired using the HDR source and the flat panel detector.
The activity of the HDR source will produce projections of the markers on the flat panel detector
and these can be captured on the detector from the control area by activating the start tracking
process using a MATLAB GUI from the control area. The images obtained are named and saved
in a specified directory in the remote computer controlling the image detector (control area).
These images are then converted to DICOM format via MATLAB code and are processed by
MATLAB.

Figure 29: Grey scale image acquired using the HDR source and flat panel detector with sourcedetector distance of 50cm to check imaging geometry and quality

Figure 29 shows a gray scale image of the projection of marker when the source-detector
distance was 50cm1. In the previous research, the best quality images were produced when the
source-detector distance was at 50cm and when the markers were spaced 2cm apart. The images
were taken to check image quality; they proved that the marker could easily be seen by eye. The
best quality images were produced when the source-detector distance was at 50cm and when the
markers were spaced 2cm apart.
Now that we have our image the next step was to segment out only the markers, label them and
get their centroids. The centroid would then be used as a surrogate for the coordinates for the
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projection of the markers. Using MATLAB the raw images saved in DICOM format could be
read using the dicomread command as explained below:

Info = dicominfo(FileName);
X=dicomread(info);
“dicominfo” reads the metadata from the DICOM file specified by the string “FileName” and
store it in the variable info. “dicomread” then reads the image data from the DICOM metadata
structure “info” and stores it in variable X.
The image data contains ample information including, coordinates of the marker, patient
information, applicator coordinates, projection of the markers, random noise etc. Image
averaging and noise filters were used to remove the noise. Once a smoother grayscale image with
minor grains is obtained, the aim was to segment out only the markers and leave out the noise.
Given that the shape of the markers was known before hand, morphological operations is used to
localize and segment the marker. A threshold is applied to convert the grayscale image to a
binary image in which the markers are represented by ones and the rest by zeros (image
processing explained later in the chapter). From the binary image the markers could be easily
segmented, labeled and their centroids could be calculated.

Figure 30: Binary image obtained after morphologically processing and segmenting the
grayscale image.
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3.3 MEX Files
MEX stands for MATLAB executable. It is a type of computer file that provides an interface
between MATLAB or Octave and functions written in C, C++ or Fortran. When ran, they are
dynamically loaded and allow external functions to be triggered from MATLAB or Octave as
though they were built-in functions25.

Figure 31: MEX file structure

3.4 Experimental Setup
The brachytherapy imaging suite at Virginia Commonwealth University is equipped with Acuity
which is an imaging and simulation machine manufactured by Varian Medical System, Inc. For
the experimental setup we used the: the flat panel detector setup, the after-loader, guide
tubes(catheter), a 5cm solid water phantom, test catheter and the operating couch.
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Figure 32: Representation of the experimental setup

The detector used in this experiment is a new highly sensitive flat panel detector from Varex
Imaging which is a branch of Varian Medical Systems Inc. The flat panel detector setup has an
arm that attaches it firmly to a stand. The arm can be moved through several angles to acquire
images. The total pixel area of the detector is approximately 40cm(h) × 30cm(w), with a total
pixel matrix of 1088(h) × 896(w) at half resolution and 2176(h) × 1792(w) at full resolution. For
all the experiments the detector was used at full resolution, contrary to the previous work1, and
with a pixel size of 0.0388cm.

Figure 33: Arrangement of matrix of markers

A mount was made from Plexiglass to hold the markers at a fixed height above the detector. The
plexiglass was permanently mounted atop the flat panel detector with the help of screws.
Adjustable screws are also made available to control the height of the mount. The markers are
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arranged in the form of a well-defined matrix. Figure 33 shows a well-defined arrangement of
markers above the detector’s receptor area.
Iridium 192 was the HDR source, it was stored and delivered via the after-loader present in the
suite. The after-loader used was VariSource iX, bu Varian medical systems Inc. The after-loader
serves as a storage location for the HDR source; it can shield the environment from the source.
The HDR source is normally present at the tip of a source in the after-loader; this way it could be
delivered and retracted into the after-loader from a remote operating console for safety reasons.
The remote operating console uses a source control and drives mechanism to sort, control and
move the source into specific positions for a specified amount of time. The after-loader has
twenty output channels, with guided tubes connected to each output. The HDR source can be
delivered via any of the twenty output channels. The guide tubes are long rubber catheters which
connect one of the output channels of the after-loader to the test catheter.
The test catheter used for this experiment is made of plexiglass. It has a thickness of
0.6cm. The plexiglass sheet contained horizontal cylindrical holes of 0.5cm in diameter which
were sealed from one side and open from the other. The test catheter was placed inside these
holes with some part of the catheter left outside the plexiglass. The guided tubes were clipped on
to the part of the catheter left outside the plexiglass, thus creating connection between the afterloader and the test catheter.

Figure 34: Test Catheter with flat-panel-detector-set positioned below it
A 5cm solid water phantom was used to mimic the patient. The test catheter was place on top of
the solid water and this arrangement was placed on the operating coach to portray an actual
treatment scenario. The after-loader delivers the HDR source through the guided tubes to a
position in the test catheter and holds the source in that position for a given amount of time.
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3.5 Calibrating the System
This process comprises two steps. Firstly, the exact height between the marker plane and the
detector plane is calculated. Next, we calculate the coordinates of the position of the markers
with respect to the origin. Since the actual surface of the detector (image sensor) is packaged
within the cover of the flat panel detector, the height between the markers and the detector
cannot be manually measured, accurately. The Plexiglass mount used to place the markers is
currently stably mounted. An x-ray source placed at a known height was used to acquire images
for calibration.

3.5.1 Calculate Height: To calculate the coordinates of the markers on the marker plane, the
exact height between the two planes must be known. Figure below represents the image acquired
using the x-ray source. It is a grey scale calibration image and the red dotted line represents the
central axes.

Figure 35: Grey scale calibration image1

The markers are arranged such that there exists an array of markers along the x-axis and y-axis.
The markers on the central axis are used to calculate the height between the two planes. From
Figure 35, a marker exists on the axis of the origin. Using this marker as a reference, we can
calculate the distances to other markers and projections along the x-axis and y-axis.
Morphological image processing is applied on raw images to segment and label them, after
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which the centroid of the projections of the markers is calculated. This way we can get the
distances between the projections of the markers. Using these distances, we can calculate the
height H using the formula below.

Figure 36: Schematic representation of height calculation1.

Assuming M1 is the marker on the same axis as the origin, with its projection as P1, and M2 is
the represents any other marker along the x-axis or the y-axis with P2 as its projection. This xray source is kept at a fixed distance from the detector which can be electronically controlled
from the operating console. For the first and second trial this distance was fixed at 150cm1, and
for the third trial it was fixed at 170cm1. H represents the height between the markers from the
detector, X2 represents the distance between the markers on the marker plane and X1 represents
the distance between the projections of the markers on the detector plane.
The coordinates of the centroid in the segmented image represents the pixel. This can be
converted to centimeters by simply multiplying it with the resolution of the flat panel detector,
0.0388cm. Once the coordinates are converted to centimeters X1 is calculated by subtracting the
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coordinates of the markers along the x and y axis from the origin. X2 is manually calculated
using a foot ruler.
Looking at Figure 36, Tanθ can be represented by two equations
Tanθ = X2 / (150 – H)
Tanθ = (X1-X2) /H

The formulas above, produces the formula below when solved simultaneously.
H = 150*(X1-X2) / X1
The above formula will give the value of H for one marker with respect to the central marker.
This same procedure is repeated to calculate the distances between all the markers and its
projections with respect to a selected origin. Using the distance H is calculated for the respective
markers and a mean of all the H’s is used as the height between the marker plane and the
detector plane.
This procedure was used for the first two trials. The third trial had the x-ray source placed at
170cm from the detector1. Every other procedure remains the same, except the formula for the
calculation of H:
H = 170*(X1-X2)/X1

3.5.2 Calculate the Coordinates of the Markers: The unprocessed detector image used to
calculate the height is also used to calculate the coordinates of the markers. The origin is
assumed to be the center of the detector for all coordinate calculation purposes. For calibration
purposes the x-ray source is placed along the z-axis at a height of 150cm, so that the x-ray source
has the coordinate of [0, 0, 150]. The height at which the markers are placed represents the zcoordinates of the markers with the x and y coordinates unknown, i.e. [x, y, H]. H is calculated
using the formula for H. The aim here is to calculate the x and y coordinates of the markers using
the coordinates of the projection of the markers on the detector.
The steps taken to get some much-needed coordinates are as follows: first the image is acquired,
then it is processed so that it can be segmented and labeled. The centroid for each of the labeled
marker is then calculated with respect to the origin. The coordinates of the centroid are converted
to centimeters using the resolution of the detector. Once the coordinates of the x-ray source, the
projection of the markers and the z-coordinate of the markers are known, the 3-D coordinates of
the markers can be calculated using the equation of the line in space. These processes were
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accomplished using a custom written algorithm implemented using MATLAB and the image
processing toolbox.
Figure 37 shows the x-ray source placed at point S[0, 0, 150], two random markers used for
calibration C1 and C2 and their projections C3 and C4. From the figure we observe that S, C1
and C3 form a straight line in 3-D.

Figure 37: Represents a schematic for calculating the coordinates of the markers from the
calibration image1.

The line can be represented by the three parametric equations:
X = x1 + t(x2-x1)
Y=y1+t(y2-y1)
Z=z1+t(z2-z1)
Where t varies from -∞ to ∞
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The 3D coordinates of the source S and point C3 are known. The z-coordinate for point C1 is
also known1. Substituting the values of the z-coordinates in the equation for Z we get t = H/150.
By substituting the value for t and the values for x and y coordinate of the source and the
projections in the equations of X and Y, the 3-D coordinates of the markers with respect to the
origin is calculated.

3.6 Test Plans
A plan gotten from CT and stored in a database as shown in Figure 38, below is used in this
treatment. The plan comes in the form of a DICOM file which is imported, processed, displayed
and utilized by both our standalone system (MATLAB based) and the actual treatment system.
This was to help us determine the exact position of the HDR source and the path it follows. The
information gotten from this is used to reconstruct the source, the applicator, and their path, and
display it on our GUI. The accuracy of the system can be checked by comparing the coordinates
of the reconstructed source to the coordinates of the planned dwell positions of the treatment
plan. While the actual treatment machine can easily work with this plan, we are designing our
system to work with it as well as will be seen below.
During brachytherapy treatment, the x-ray source is placed at dwell positions for a given dwell
time. Dwell positions are distances measured with respect to a reference point. In our
experiment, the tip of the test catheter was considered as the reference point as well as the 1 st
dwell position.
The after-loader delivers the source from one of its output channels to the test catheter via guided
tubes. The test catheter is positioned at the isocenter1. In radiation physics the isocenter is the
point in space through which all the radiation beams intersect and the central beam passes
through. The Acuity machine software allows the user to adjust the distance between the
isocenter and the detector. Therefore, the catheter had to be placed at the isocenter. Figure 39
represents the schematic for the test plans.
Following the same system of axes, the tip of the catheter is placed at the isocenter. The system
of axes is chosen such that the isocenter falls on the z-axis. Once the catheter is located at the
isocenter, the source-detector distance can be adjusted with the help of the simulation software of
Acuity.
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Figure 38: Schematic explaining the test planning and treatment delivery

The catheter arrangement is placed on the operating couch and the flat panel detector is kept
parallel to the couch. The catheter is aligned along the x-axis with its tip on the z-axis at the
desired height from the detector. By this arrangement, the source will only move along the x-axis
with respect to the tip of the catheter, while its position on the y-axis and z-axis remains
constant.
The exact length of the guided tube as well as the length of the catheter must be measured and
known. In other to send the HDR source to the first planned dwell position. This is done via a
measuring wire which measures the distance the source has to travel from the output channel of
the after-loader to the tip of the guided tube. The length of the catheter is added to this distance
to get the start point that the after-loader must send the HDR source, so that it is delivered at the
first planned position. This QA procedure must be followed before every treatment.
The second phase of the brachytherapy treatment plan is setting the dwell time. This is the
amount of time for which a source will remain at a given dwell position.
Image acquisition was done via C codes, with the intention to later wrap this code as a MEX file,
and repeat the same thing using a GUI. The number of images and the directory to which they
were to be saved for easy access, as well as several other properties was specified within the C
codes.
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3.7 Trials
A test plans was created to mimic an actual clinical scenario. The plan was created on the
software that controls the afterloader. This was to help us determine the exact position of the
HDR source and the path it follows. Once the exact planned 3-D coordinates of the treatment
trials are known, images are acquired using the HDR source and used to reconstruct the source.
The accuracy of the system can be checked by comparing the coordinates of the reconstructed
source to the coordinates of the planned dwell positions of the treatment plan.
In the previous research, 50cm to 70cm was observed to be a comfortable distance to place the
detector from the patient’s-HDR-source, in other to get good quality images and retrace the path
of the source. That concept was employed in this research as well.

Figure 39: Schematic explaining the positioning of the test catheter and the test plan

3.8 Image Acquisition
Image acquisition was a very critical process since we were using a new detector; the Paxscan Xray detector. As compared to the previous study on this subject 1, our planned method of image
acquisition here is via a C language code, incorporated into a MATLAB GUI. Initially, images
were grabbed using the VIVA software provided by the manufacturers of the detector, but this
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doesn’t give us the flexibility that we need to design our custom program which was used to
acquire our images, using the developer resources provided. The Varex detector allows us to
acquire images in four distinct modes: fluoroscopy (fluoro) mode, dynamic gain mode, dual gain
mode, and radiation (rad) mode.
In fluoro mode, image acquisition is continuous, while in rad mode, images are acquired under
software or hardware handshaking control; typically, one image is acquired and saved, though if
the number of accumulation frames is set to more than one, then the sum is formed29. In dual
gain mode each pixel is read at high and low gain. Dynamic gain mode is a special dual gain
mode in which each pixel value is read once only at high or low gain; this mode is also referred
to as dynamic gain switching (DGS)29. In this research we used the fluoroscopy acquisition
mode.
The original C code provided by Varex, was written around 2009 or earlier using visual studios.
The code has certain dependencies which could potentially stop it from working completely, or
even when it does work at-times, it just doesn’t give the expected result. Two notable
dependencies come from the software setup file that installs the detectors original software
(VIVA – Paxscan Virtual CP L07). First is the ebus driver (PaxscanPleoraSupport) which helps
establish communication between the host computer and the detector, then the manufacturer
driver. The manufacturer driver install option comes after the ebus driver has been installed and
isn’t stated in the installation manual. One must be careful to ensure that both are installed to
avoid strange errors and problems. Another dependency is the Visual C++ redistributable 2010
version; the exact version is shown in Figure 40 below. The installation of this Visual C++
dependency can be done in one of two ways. First is by, downloading the exact version from the
Visual studios website, and installing it or second (recommended), by uninstalling all version of
Visual C++ redistributable above 2009. By doing this, when the VIVA setup file is run it
automatically installs the needed version. Note that there would be an installation error if any
version above 2009 is already installed and the installation process might need to be restarted.
After installing this dependency you’ll need to reinstall the redistributable file for the version of
Visual studios that you have installed on your PC. For example, if you have visual studios 2017,
then you should also have the 2017 redistributable installed after this.
Finally, the receptor setup file (444S03-0705 folder) that comes from Varex must be copied and
pasted in the IMAGERs folder29, or any other folder where you want the recorded images to be
stored, else the entire C program or software won’t be able to grab images.
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Figure 40: Shows a highlight of the exact version of Visual C++ Redistributable 2010 that
software and custom code depends on.

Figure 41: Structure of image capturing program

Figure 41 above, gives a clear and brief description of the operation of the C code used to get the
images. Before we delve into much detail about Figure 41, it’s important to know that certain
standards must be met for the code to operate as desired. First, all calibration and configuration
files must reside on the host computer while software runs on it. VirtCplib which is a library that
was provided with the sample code provided by Varex, expects all these calibration and
48

configuration files to be organized into a fixed tree of subdirectories. It is very important to note
that the root of this subdirectory tree may be chosen by the user, but the recommended
configuration (the VIVA default) is to name the directory IMAGERs (C:IMAGERs), with one or
more subdirectories whose names are the serial numbers of the receptor panels that have been
installed29. This path is saved in the registry and only needs to be set once on any computer.
The VirtCP.dll provided by Varex, reads in calibration files so that it can correct raw images
acquired from the X-ray imager panel. The files are read when vip_open_receptor_link() is
called: the RecDirPath member of the SOpenReceptorLink structure is expected to be a path
name to the calibration tree. The recommended convention is to name this tree
C:\IMAGERs\serialnbr. For example if the imager serial number is 1234-56, this path is
C:IMAGERs\1234-5629. VirtCp.dll is dependent on four other dlls, and at run-time a user links it
to them when the receptor link is opened, the include: HcpImgAcq.dll which controls image
acquisition and interfaces to I/O devices which may control the x-ray generator; HcpRecCtrl.dll
which controls the receptor, stores information parsed from the receptor configuration file and
interfaces to frame grabber module; HcpCorrections.dll which performs image corrections and
processes calibration data; and HCPCalibration.dll which controls acquisition of calibration data.
These four modules in turn generally have other device-specific dependencies29. Severally other
.dll-extension files are provided with the program, and to avoid any run-time-errors or problems
in general, they were also placed in the folder where are had all the codes. One important thing to
also look out for when reading through the resources (codes) provided by Varex is that function
names are prefixed with vip_(small letters) and constants are prefixed with VIP_ or HCP_
(capitalized for both cases).
Now we’re set to describe the program/code structure and working pattern. First, our
program includes an error check because there are many challenges that could be experienced
practically when the detector is exposed to radiation, or when dealing with. Our expectation is
that it works as desired and that when it isn’t some sort of notification should be sent to avoid
any major problem. After error check is passed, vip_open_receptor_link() proceeds to open
receptor link; this must be done before nearly any function is called. While opening receptor link
the receptor mode is also set (vip_fluoro_init_mode()), in this case it’s set to fluoro mode. After
that we set the frame rate, which could be entered as a fixed number or set to ‘0’ which
represents continuous image acquisition. Now, vip_fluoro_get_buffer_ptr() points the program to
a memory block which receives the image. This memory block must be at least (2 * x-size * ysize) bytes; once the receptor is recognized vip_fluoro_grabber_start() starts grabbing the images
an sending them to the allocated block. In our case we get an image size of approximately 7MB
(7,798,784Bytes), which is the product of (2*2176*1792).
Vip_fluoro_grabber_start() works in conjunction with the vip_fluoro_get_prms call which
provides the range of available indices. There are normally two grab buffers allocated which are
accessed directly by the frame grabber. It will normally write to these buffers alternately – ‘pingpong’ fashion after a call is made to vip_fluoro-grabber_start(), and continue doing so until
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vip_fluoro_grabber_stop() is called29. Pleora (driver) provides a buffer class which allocates
multiple buffers for a single class object. At this point vip_fluoro_record_start() starts copying
image frames from the grab buffers to sequence buffers, beginning with buffer index 0 -until
vip_fluoro_record_stop() is called or the requested number of frames have been captured.
Corrections are also made simultaneously/are automatically applied in fluoro-mode if necessary
by vip_correct_image(). If a specific number of frames is requested, at least that number of
buffers must be allocated. If acquisition is free-running then buffers are written in circular
fashion, meaning that once the allocated buffers have been filled, the earliest frames acquired
will be overwritten. Note that if this happens and the sequence acquisition is stopped arbitrarily,
the sequence ‘start index’ will generally not be zero. The start index may be discovered after the
sequence has stopped by calling vip_fluoro_get_prms() referencing SSeqStats.
After vip_fluoro_record_stop() function is called and no more frames is been copied to the
sequence buffers, and error check is done, if this passes, vip_fluoro_get_buffer_ptr() function
repoints to the location (directory) where our images will be saved. When this process complete,
vip_close_link() function closes the link. The close function is very important and should only be
done when the acquisition session is finished. This function frees some of the resources and
memory associated with the receptor. Memory allocated for sequence buffers is by default not
deallocated until VirtCp is detached. This behavior can be modified by following the instructions
in the user manual29.
Prior to running the test plan, we acquired images using our native codes without the
HDR source. This raw image as shown in figure 42 below is used for morphological image
processing.
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Figure 42: Raw greyscale image from detector

They are subtracted from the images acquired with the HDR source. At this point the result of
such subtraction consider any exposure or noise produced by the leakage of x-ray from the
source. A series of images were further taken by the afterloader at distinct planned dwell
positions. The images produced were a projection of the markers on a setup mounted on the flat
panel detector and placed between the HDR source sent by the afterloader and the flat panel
detector as shown in figure 43 and 44 below.

Figure 43: Filtered raw image
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Figure 44: Result of Subtraction of filtered image

Dwell time was set such that we that we could take good sets of images, but normally images
acquisition took less than 10seconds when all parameters for image acquisition were set and in
place. The images were acquired and saved via a custom MATLAB GUI which calls in a Cfunction to communicate with the detector and acquire the images. The acquired images are
saved in “.raw” format, read into MATLAB processed and saved in DICOM form. The images
acquired here show significant improvement from that taken using the previous detector, but we
still did an averaging over five images to get a better image and reduce noise significantly. The
concept behind averaging is that random fluctuations of the noise above and below the projection
of markers will gradually cancel each other out, thus improving the signal to noise ratio.
Noise at the edges where cropped out by pixel adjustment, using the code structure below:
I=X(26:743,26:999);
Where X is the original image after image averaging and the cropped image is stored a new
variable I. One noticeable improvement of the new detector is its resolution of 2176 by 1792, and
better sensitivity of its receptors.

3.8.1 Morphological Image Processing
Now that we have our noise-reduced-images saved in DICOM format, they are now ready for
processing in MATLAB. The images are processed at this point to fathom, the 3-dimensional
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coordinates of the projection of the markers. The centroids of the projection of the marker on the
acquired images are used as surrogates for the 3-dimensional coordinates1.
At this point morphological image processing is performed on our image to isolate the shape and
size of the markers and obtain the coordinates of the centroid. ‘imbothat’ command from
MATLAB image processing toolbox was used to perform bottom-hat filtering on our grayscale
image. The bottom-hat filter requires a structuring element which would define the shape of the
markers1. Since the markers are circular structures we define a structuring element of type ‘disk’
using the ‘strel’ function. The filtered image is then stored as a new variable. Below is an
example of the using of both functions.
Se = strel(‘disk’,25);
I1 = imbothat(I,se);
The codes above create a flat disk-shaped structuring element ‘se’ with a radius of 25 pixels. The
bottom-hat function is performed on the cropped image ‘I’ using ‘se’ and stores it in I1. Apart
from the bottom-hat filter, wiener2 and medfilt2 filters were also used. Wiener2 is a 2-D
pixelwise adaptive Wiener filtering method which acts as a lowpass filter to improve a degraded
grayscale image by removing the noise; it works based on statistics estimated from a local
neighborhood of each pixel 1. Medfilt2 on the other hand is a two-dimensional median filtering
technique which is used to reduce tiny pixels of noise. The code for both filters are given and
explained below.
[I2, noise] = wiener2(I1,[15 15]);
I3 = medfilt2(I2,[8 8]);
In the first line, a 15 by 15pixel size neighborhood was used to estimate the local image mean
and standard deviation to perform the wiener2 filtration function on the image labelled I1, and
the filtered image is stored in I2. In the case of medfilt2, an 8 by 8pixel size neighborhood was
used around each pixel in I2 to perform median filtration. The filtered images were then stored in
I3.
After these we are set to isolate the markers as a next step. The grayscale image is converted into
a binary image such that only the markers take the value 1 while the rest of the image is 0. This
is done by applying a threshold to the image, as shown below.
I4 = I3>mean2(I3) + 2.5*std2(I3);
From the code above, the mean value is added to 2.5times the standard deviation value and used
as a threshold which is applied to image I3 and the resulting binary image was stored as a
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variable I4. From I4, the markers can be isolated, labeled and the centroids for each marker can
be calculated using the code described below.

[I5,NUM]=bwlabeln(I4);
STATS=regionprops(I5,’Centroid’,’Area’);
The ‘bwlabeln’ jfunction labels the markers in the image I4 and stores the result in variable I5.
“regionprops” function measures the centroid and area of the labeled markers in the image I5 and
stores it in the array STATS. The x-y pixel coordinates of the centroids can be accessed using the
Comma-Separated List Syntax as explained below,
STATS.Centroid
The centroid acts as substitute for the coordinate of the markers and is represented by the pixel
number. To obtain the coordinates with respect to the system of axis that we chose, the x and y
coordinates of the pixel number of the centroid must be subtracted from the center of the
detector. The coordinates are converted into centimeters by multiplying the pixel number with
the pixel size or the resolution of the flat panel detector.
As compared to the previous work on this research where the detector, was set at half resolution,
we used the full resolution in this case with a pixel size of 0.0388cm. Converting pixel numbers
to centimeters simplified calculations for the reconstruction of the source. The same procedure
was carried out for the calibration image and the 3-dimensional coordinates of the markers were
also converted into centimeters. Figure 45 depicts a segmented and labeled image which was
acquired for the first dwell position of the second test plan.
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Figure 45: Binary image obtained after morphologically processing and segmenting the
grayscale image.

3.8.2 Reconstruction of the source
Since the goal of this research is strongly related to locating the source position, much attention
was given to this section. After analyzing the images for all dwell positions for all the test plans
it was observed that the coordinates of the projections of the markers were unique for each dwell
position. This demonstrates that the coordinates of the projection of the markers are correlated to
the position of the source. The calibration method gives the exact 3-D coordinates of the
markers. The exact 3-dimensional coordinates of the projection of the markers are further
obtained by processing the images acquired using the HDR source. Using these 3-D marker
coordinates and projections, the positions of the source is formed by pairing each marker with its
projection and calculating the shortest distance. This we did by providing a label to each blob on
the marker image and the projection image and with the help of the label number the marker is
paired with its respective projection.
After labelling the segmented image, the markers get labeled in any random order. Thus
the labelled markers needed to be rearranged such that we have the same order for the markers
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on the calibration image and the projection of the marker on the image acquired via the HDR
source. This makes the pairing of markers with its respective projection much easier. “sort”
command in MATLAB was used to perform this function. It sorted the coordinates of
projections and stored them in a variable called ‘img’ while the sorted coordinates of the markers
are stored in a variable called ‘cal’.
Lines in 3-D are defined with the help of the 3-D coordinates of the marker and its
respective projections. Two lines defined by two marker-projection-pair are used at one time.
The intersection of both lines defined the source position. The intersection of the two lines in 3D is very unlikely practically, so a method was devised were the shortest line segment which
connects the two lines in 3-D was used for further computation. This line segment is considered
the intersection of both lines.

Figure 46: Intersection of two lines in 3D1.

From the figure 46, line p is defined by the marker P1 and its projection P3 and
represented by the equation 1; line q is defined by the marker P2 and its projection P4 and is
represented by the equation 2
P = P1 + mup * (P3-P1)-------------(1)
Q = P2 + muq * (P4-P2)-------------(2)
P and Q represent the points on the lines p and q which give the shortest distance between the
two lines. The values of mup and muq range from negative infinity to positive infinity.
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The shortest line segment between the two lines should be perpendicular to the two lines.
Thus, two equations for the dot product are represented as
(P-Q) dot(P3-P1)=0
(P-Q)dot(P4-P2)=0

Expanding the above equations using 1 and 2 we get,
(P1-P2+mup*(P3-P1)-muq*(P4-P2))dot(P3-P1)=0
(P1-P2+mup*(P3-P1)-muq*(P4-P2))dot(P4-P2)=0

Both equations above represents two equations with two unknowns mup and muq, thus solving
the above two equations simultaneously gives the values of mup and muq. The coordinates of P
and Q is derived by substituting these values in equations 1 and 2. The mean of P and Q is used
as the position of the source.
The procedure above is repeated for all the possible combination of marker projection pairs.
Thus, N markers would produce N*(N-1)/2 combinations of marker-projection pairs, each pair
given a shortest distance D and a P and a Q. The mean over all the P’s and Q’s will give the most
accurate position of the source.
The above processes, were all implemented via MATLAB: the reading of the five DICOM
images, the calibration image and the blank image; averaging and subtraction of images for noise
cancellation, system calibration, segmenting and labeling of all the HDR images, calculating the
coordinates for the calibration of HDR images, sorting out the labelled images, pairing the
markers with their respective projection and finally calculating the shortest distance and the
coordinates for the points of intersection. This helped us locate the position of the source in 3D
and implement the entire process in MATLAB.

3.9 GUI Design
All the monitoring operations of our standalone system will be performed by the MATLAB GUI
in Figure 48 below. The entire testing processes described above, from image acquisition
through source reconstruction, will be controlled from the GUI. The GUI interface is
programmed such that on clicking the start tracking button, all the functions associated with the
tracking process begins to run, and the desired output are displayed in the axis. These processes
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will include the image processing procedures listed below, arranging as sequential function
within our code:
•
•
•
•

Image Enhancement – Noise removal, deblurring, filtering
Image Segmentation
Image Analysis
Morphological Operations

The codes for these image processing procedures were mostly gotten from previous research on
this topic. While the code that acquires the image, and the MEX file, and GUI and a few other
extra codes are a product of this research.
It is assumed that by using all the results from all the codes run by our standalone system, the
changes in the source position could be tracked as shown in the image below.

Figure 47: Effect of change in source position
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Figure 48: MATLAB GUI

3.9.1 Tracking Versus Prediction Mode
Figure 49 below gives a glimpse of what tracking mode signifies. In this mode the movement of
the source along the catheter is monitored on the GUI in real-time, while treatment supposedly
takes place. By default, our system runs in this mode when the “Start Tracking” button in Figure
49 is clicked. In this mode the source path is also plotted, and several other information can be
found on the GUI.
Prediction mode makes a little change to the GUI. This mode is activated by clicking on the
“Prediction Mode” button on the GUI. In this mode the system check if the source is in a dwell
given position for a given time and if it meets the quality assurance standard predefined by us. If
the standard is not met, indicators (green, red, yellow indicators) will begin to blink on the GUI
to inform us of the degree of violation of our set standard. This way we can know if we need to
shut-down treatment and what step to take. In prediction mode, the system also keeps record of
passes and fails for the dwell positions and their corresponding dwell times.
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App.2 App.3 App.4 App.5 App.6 App.7 App.8 App.9
0
0.1
0.1
5.0
5.0
5.0
5.0
5.4
5.4
8.7

0
0.2
0.2
1.9
1.9
4.9
4.9
5.2
5.2
7.3
7.3
7.6
7.6
8.1
8.1
8.1
8.1
9.6
9.6
9.9
9.9
10.2
10.2
11.9
11.9
12.7
12.7
15.2

App
11
0
1.5
1.5
4.1
4.1
4.6
4.6
7.0
7.0
10.1

App
12
0
3.0
3.0
4.1
4.1
4.2
4.2
10.6
10.6
10.7
10.7
11.0
11.0
13.3
13.3
15.1
15.1
15.8
15.8
17.6
17.6
17.8
17.8
18.8
18.8
20.1

App
13
0
1
1
1.7
1.7
2.1
2.1
2.5
2.5
3.1
3.1
3.3
3.3
3.6
3.6
5.2
5.2
5.7
5.7
6.1
6.1
6.4

0
0
0
0
0
0
3.0
1
3.2
4.4
0.1
4.2
3.0
1
3.2
0.1
4.2
4.5
1.7
3.2
4.0
5.6
4.5
1.7
3.2
4.0
5.6
4.6
3.3
6.0
4.7
6.6
4.6
3.3
6.0
5.0
6.6
6.0
4.7
6.8
5.0
6.7
6.0
4.7
6.8
6.1
6.7
8.0
4.7
9.3
6.1
7.6
8.0
4.7
9.3
8.5
7.6
8.5
6.8
10.2
8.5
7.8
8.5
6.8
10.2
8.6
7.8
8.5
8.7
13.9
8.6
8.4
8.5
8.7
13.9
9.2
8.4
9.9
8.8
13.9
8.5
9.9
8.8
13.9
8.5
10.2
9.9
16.2
8.8
10.2
9.9
8.8
10.8
10.6
8.9
10.8
10.6
8.9
11.5
15.5
9.2
11.5
15.5
9.2
12.5
16.0
10.3
12.5
16.0
10.3
13.5
17.1
11.4
13.5
16.1
16.1
16.1
Table 1: Cumulative-time-weights for the all dwell positions in each catheter arranged
sequentially as a factor of time (Nth second at Nth Position)

App
14
0
1.2
1.2
1.3
1.3
1.8
1.8
2.5
2.5
2.8
2.8
2.9
2.9
3.0

From Table 1, applicator 2 has 10 dwell positions, applicator 3 has 28 dwell positions, applicator
4 has 30 dwell positions, applicator 5 has 26 dwell positions, applicator 6 has 18 dwell positions,
applicator 7 has 2 dwell positions, applicator 8 has 16 dwell positions, applicator 9 has 26 dwell
positions, applicator 11 has 10 dwell positions, applicator 12 has 26 dwell positions, applicator
13 has 22 dwell positions, and applicator 14 has 14 dwell positions.
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In other to create a MATLAB function that simulates the source movement, we applied
differential equation to the cumulative-time-weights for the various dwell positions for each
catheter. The code below shows the logic applied.
DwellT_Item1=diff(CTimep(1:10));
This equation displayed the differences in time for all the Nth-cumulative-time-weights in Table
1 above, belonging to each catheter. By applying this equation to App.2 (Table 1) for example,
we got: 0.1, 0, 4.9, 0, 0, 0.4, 0, 3.3. Another MATLAB algorithm as seen in the equation below,
was then applied to remove the zeros, which leaves us with 0.1, 4.9, 0.4 and 3.3.
DwellT_Item12(DwellT_Item12==0)=[];
Adding all this together we get 8.7 which is the last cumulative-time-weight for the source in
App.2. These time changes are then used to create Table 2, and the animated simulation of the
source movement.

Figure 49: Realtime Simulation in GUI
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Figure 50: Logic behind prediction mode color indicator in GUI
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CHAPTER 4 RESULTS
To test our design a simulation which portrays the animated movement of the source along
several dwell positions was created. This simulation runs without communicating with the
detector. The assumption here is that the C-program in the form of MEX file gives absolutely no
problem and runs perfectly.
With a total of 113 dwell positions, along 12 distinct channels, the expected total dwell time is
137.9seconds while it took an average actual time of 145seconds for our system to completely
run, as estimated by the tic/toc function in MATLAB. This is about 7.1second behind the actual
treatment time. In Table 3 though, we got a total average of 151.83seconds, which is roughly
14seconds shy of the expected value. This could be attributed to human error, because the actualtimes used to calculate the averages in Table 3 were done using manually using the timer on a
phone which definitely influenced its accuracy.

App.2 App.3 App.4 App.5 App.6 App.7 App.8 App.9 App App App App
11
12
13
14
0.1
0.2
3.0
1.0
3.2
4.4
0.1
4.2
1.5
3.0
1.0
1.2
4.9
1.7
1.5
0.7
2.8
3.9
1.4
2.6
1.1
0.7
0.1
0.4
3.0
0.1
1.6
0.8
0.7
1.0
0.5
0.1
0.4
0.5
3.3
0.3
1.4
1.4
2.5
0.3
0.1
2.4
6.4
0.4
0.7
2.1
2.0
2.1
0.9
1.1
0.9
3.1
0.1
0.6
0.3
0.3
0.5
1.9
3.7
2.4
0.2
0.3
0.2
0.1
2.1
1.4
0.1
2.3
0.1
0.6
2.3
0.3
0.1
0.3
0.3
1.1
0.6
0.1
1.8
1.6
0.5
0.6
0.7
0.3
0.7
0.5
1.5
0.7
4.9
0.1
1.8
0.4
0.3
1.0
0.5
0.3
0.2
0.3
0.3
1.0
1.1
1.1
1.0
1.7
2.6
1.1
1.3
0.8
2.5
Table 2: Shows sequential time changes after applying differential function to Table 1, and
taking of the zeros that represents no change
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For all the time changes in each column above which represents a movement from one position
to another, a radiation of strength: 37552.28 cGy cm2/h is applied. This is intended to meet the
prescription of 3400cGy-in-10-fractions, which is the prescription we created for our sample
patient.
Success in Table 3 below, is defined as those points in time when the differences in delay is less
than 1.5seconds.
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Expected
Cumulative
Dwell time
(Seconds)

Actual
Averaged Difference Failure
Success
Cumulative
Actual
(Seconds)
Dwelltimes Cumulative
(Seconds) Dwelltimes
(Seconds)
Applicator
8.7
15.52
14.6
5.9
1
0
2
14.12
14.18
Applicator
15.2
18.27
18.66
3.46
1
0
3
18.93
18.78
Applicator
16.1
14.74
14.65
1.45
0
1
4
14.60
14.61
Applicator
17.1
19.45
19.53
2.43
1
0
5
19.48
19.65
Applicator
16.2
15.86
15.85
0.35
0
1
6
15.93
15.77
Applicator
4.4
6.16
6.25
1.85
1
0
7
6.52
6.08
Applicator
9.2
9.73
9
0.2
0
1
8
7.12
10.13
Applicator
11.4
12.71
11.25
0.15
0
1
9
8.59
12.45
Applicator
10.1
10.36
10.47
0.37
0
1
11
10.53
10.53
Applicator
20.1
21.07
20.92
0.82
0
1
12
20.82
20.88
Applicator
6.4
7.24
7.33
0.93
0
1
13
7.67
7.09
Applicator
3.0
3.30
3.32
0.32
0
1
14
3.12
3.54
Over All
137.9
151.83
4
8
Table 3: Shows the total number of failures and successful treatment delivery in each catheter
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Figure 51: Expected cumulative dwell-times versus actual cumulative dwell-times

From Figure 51, the most deviation of actual dwell-time from the expected dwell-time was in
applicator 2. It could be observed when starting the program that there was always a longer time
delay at this point, probably because the program had to load the patient’s DICOM information
from the plan and structure file before displaying any result. Using the 1.50second difference
limit as a measure of successes or failure, we could state that there is approximately a 33%
chance of failure (4 of 12) and 67% chance of success (8 of 12).
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CHAPTER 5 DISCUSSION AND FUTURE DEVELOPMENT

Currently, this system is very sensitive, and numerous errors can occur when working with it,
which might require us to restart the monitoring system, and which could result in very bad
consequence in the real world. One problem encountered when working with the detector, was
that during image acquisition, when the radiation source exited the afterloader the system
developed errors and we had to restart the acquisition process. This could possibly be due to
communication errors caused by the radiation signals interfering with the signal running in the
ethernet cable that connects the computer to the detector. But whatever it was, it seemed to
normalize after a while. This didn’t always happen as well.
Based on information in the detector user manual, sometimes there are rare cases where firewalls
are problematic, in such cases we are provided with the device’s media access control address
(MAC address) in the HcpConfig.ini file, which comes with the other installation programs.
I also recommend that Visual Studios should be installed on any computer running this program,
because some dependencies which it works with might be only accessible from the software,
such as Visual C++ VirtCp.dll.
All in all, our system seems to be progressing in the right direction, with many signs of good
discoveries that could be made soon. As a final recommendation, I believe this project is possible
and it will be more efficient if the final system (after the full system is built) is redesigned in C or
C++, because they both perform a lot better when dealing with complex codes like the one used
in this project, and image processing of images of size 7MB.
So far, I have been able to find only a single similar work on this topic 17,22, titled BrachyView.
In this research, the HDR BrachyView probe is an in-body pinhole imaging system designed for
real-time source localization during prostate HDR brachytherapy procedures. In this project they
used an arrangement of Source, BrachyView probe collimator (fabricated with cylindrical
Tungsten-alloy shell) and pixelated silicon detector material. The collimator has an outer
diameter of 24mm, with 7-double-cone-pinholes uniformly distributed across its length with a
center-to-center spacing of 6.5mm. The tungsten material used for the collimator was chosen due
to its high mass attenuation factor, due to high energy of photons emitted by the Ir-192 HDR
source.
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The detector is a pixelated silicon detector Timepix, which is a variant of Medipix2 detector.
Each pixel in this detector has its own preamplifier, discriminator and counter. The
discriminators are used to suppress noise and select the energy range of interest. Each counter
can be configured to work in one of three modes: counting the number of detected articles,
measurement of particle energy, or measurement of time interaction. A complete imaging system
can be assembled from an array of four Timepix detectors and their associated microprocessorcontrolled USB-readout system(Fitpix). The Timepix/Fitpix system allows a frame rate of up to
400 images per second to be obtained with very low electronic noise.
The source position is determined using a simple 3-dimensional triangulation method that makes
use of the centers of mass of the projected images.

Figure 52: System arrangement 18.

In this experiment, they used the concept that since back-projected lines do not always precisely
intersect, the best estimate of the source position is the point with the minimum distance to all
the back-projected lines. No source marching is required as well since only a single source is
utilized for HDR brachytherapy.

68

Figure 53: Collimator detector operation 18.

Compared to our work, the above work is abit more invasive. while the system in this research is
passive, and in my opinion will be less precise because of the poor image averaging technique
employed. Also the detector can be placed no more than 1.5mm above the above the center of
the probe cavity to maximize the field of view .

Figure 54: Collimator structure 18.
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Figure 55: Collimator structure 18.

Figure 56: Treatment System Arrangement 13.
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Figure 57: System Arrangement 13.

The models used in their research was designed and simulated in GEANT4 simulation
application via MONTE CARLO simulation method, to validate the design.
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Figure 58: GEANT Simulator Structure 18

Results from their simulation show that errors in estimating the center of mass of the projection
in the detector plane did not exceed 1mm in worst case, and the positioning error decreases as
source is placed further away from the collimator.
In summary, running the image processing procedures above, obtaining continuous images using
an efficient C code, and integrating all the codes in MATLAB is the main goal of this research.
Proper operation, precision-measurement, as well as the addition of any extra intelligence to this
system will be a future development.
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